EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Redox modulation of antitumor immunity via nanomedicine

Xuanbo Zhang, Changrong Shi, Pei Huang, Xiaoyuan Chen

Advanced Drug Delivery Reviews · 2026-08 · 235 · 115895

DOI: 10.1016/j.addr.2026.115895 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-08. Verfasst von Xuanbo Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Hainan Medical University, Haikou, Hainan 571199, China. Electronic address: xuanbo.zhang@muhn.edu.cn. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong First Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Redox imbalance is a defining feature of the tumor microenvironment (TME). Tumor cells adapt to this oxidative pressure through robust antioxidant pathways, whereas immune cells are easily impaired, leading to poor antigen presentation, compromised T-cell dysfunction, and an immunosuppressive milieu. These redox disturbances affect nearly every step of the cancer-immunity cycle. Targeting the redox balance is thus a critical objective. However, this therapeutic avenue is fraught with challenges. The complexity and dynamic characteristics of redox regulation pose major obstacles to achieving precise modulation in the TME. Nanomedicine offers practical strategies to modulate redox dynamics, either by amplifying oxidative stress or reinforcing antioxidant capacity. This review provides a critical overview of the biological mechanisms underlying redox dysregulation in the TME, highlights nanomedicine-based interventions for precise redox modulation, and evaluates their strategic applications across the cancer-immunity cycle. Furthermore, we synthesize essential design principles to navigate the redox paradox, ultimately discussing future perspectives for overcoming translational barriers in redox-based cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanomedicineHumansOxidation-ReductionTumor MicroenvironmentAnimalsImmunotherapyOxidative StressAntioxidants

Stichwörter der Autor:innen

Cancer immunotherapyNanomedicineRedoxTumor microenvironment

Substanzen

Antioxidants

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Hainan Medical University, Haikou, Hainan 571199, China. Electronic address: xuanbo.zhang@muhn.edu.cn.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore. Electronic address: cr.shi@nus.edu.sg.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore. Electronic address: huangpei@nus.edu.sg.
  • Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan 250117, China.. Electronic address: chen9647@gmail.com.

Förderung

  • National Natural Science Foundation of China
  • Shandong First Medical University

Zitieren

APA

Zhang, X., Shi, C., Huang, P., & Chen, X. (2026). Redox modulation of antitumor immunity via nanomedicine. Advanced Drug Delivery Reviews, 235, 115895. https://doi.org/10.1016/j.addr.2026.115895

Vancouver

Zhang X, Shi C, Huang P, Chen X. Redox modulation of antitumor immunity via nanomedicine. Advanced Drug Delivery Reviews. 2026;235:115895. doi:10.1016/j.addr.2026.115895

BibTeX
@article{Zhang2026,
  author = {Zhang, Xuanbo and Shi, Changrong and Huang, Pei and Chen, Xiaoyuan},
  title = {Redox modulation of antitumor immunity via nanomedicine},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {235},
  pages = {115895},
  doi = {10.1016/j.addr.2026.115895}
}
Kostenlos starten →